Navan, Inc.
No SEC Form 4 filings for $NAVN in the last 30 days.
Prabhudas Lilladher maintained an “Accumulate” rating on Navin Fluorine International and set a target price of Rs 7,489, according to its research report dated May 25, 2026. The note outlines the broker’s expected upside for the stock, which may guide investors’ trading and positioning.
Morgan Stanley reiterated an Overweight rating and a $20.00 price target for Navan Inc. (NASDAQ:NAVN), following a proprietary Corporate Travel Survey indicating robust travel demand. The survey suggests an acceleration in travel budgets, stable air and hotel volumes, and higher-than-expected airfare increases benefiting Navan due to its per-trip fee structure. Analysts anticipate continued sales growth and potential profitability for Navan this year, with several upcoming earnings reports and a business travel benchmark data release as immediate catalysts.
Scott+Scott Attorneys at Law LLP has filed a securities class action lawsuit against Navan, Inc., its directors, officers, and IPO underwriters, alleging violations of the Securities Act of 1933. The lawsuit claims that Navan's October 2025 IPO offering documents were misleading, particularly concerning increased "sales and marketing" expenses. Investors who purchased Navan common stock during the IPO saw its value drop significantly, leading to substantial damages, with shares trading over 60% below the $25 offering price.
